From Jenna Orkin What to know about the plague after a suspected human case in Colorado Earlier this year, the U.S. Drug Enforcement Administration (DEA) proposed officially reclassifying marijuana as a less dangerous drug. The government should go further and completely remove research barriers for the substance nationwide, writes Joerg Leheste, a neuroscientist at New York Tech’s College of Osteopathic Medicine. The true potential of pot's therapeutic value remains underresearched, he says. "Large multicenter clinical studies, the gold standard for medical research examining marijuana for therapeutic purposes, are lacking as a result of high costs, regulatory hurdles, limited supply, complex approval processes, funding challenges and stigma over the past five decades." Florida Gov. Ron DeSantis signs a bill that strikes climate change from state law The names being floated as Kamala Harris' running mate if Biden drops out It Didn’t Begin with LBJ: How the US Became a Transfer Society Donald Trump’s plan for America is no secret. Beating Trump this November is the only mission. The Lincoln Project invites you to take a peek at the terrible future Donald Trump would impose on America. US Marshal involved in shooting near Sotomayor’s DC home Maps That Show How The World Really Is A nuclear accident made Three Mile Island infamous. AI’s needs may revive it. The Uncertain Outcomes of Emmanuel Macron’s Election Maneuver